a public good project by the
Synthesis
Company
of California

© 2026

Ning Zhang | doi.page

0 works0 citations0 h-index

Ning Zhang

Second Hospital of Shandong University(CN)Qilu Hospital of Shandong University(CN)

Publications by Year

Research Areas

Liver Disease Diagnosis and Treatment, Cholangiocarcinoma and Gallbladder Cancer Studies, Diet, Metabolism, and Disease, MicroRNA in disease regulation, Hepatocellular Carcinoma Treatment and Prognosis

Most-Cited Works

→ GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score(2018)210 cited
→ Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages(2020)191 cited
→ New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats(2016)113 cited
→ Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma(2015)58 cited
→ A Comparative Study on Endoscopy Treatment in Rectal Carcinoid Tumors(2012)42 cited
→ High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure(2020)37 cited

→ Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular Carcinoma(2018)

36 cited

→ Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience(2020)34 cited

→ Feasibility of machine learning-based modeling and prediction using multiple centers data to assess intrahepatic cholangiocarcinoma outcomes(2022)33 cited

→ Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis(2007)32 cited